연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
987. Human sodium/iodide symporter-mediated radioiodine gene therapy enhances the killing activities of CTLs in a mouse tumor model.
Jeon YH, Choi Y, Kim CW, Kim YH, Youn H, Lee J, Chung JK.
Mol Cancer Ther. 2010 Jan;9(1):126-33.
Link
986. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras.
Oh JS, Kim JJ, Byun JY, Kim IA.
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):5-8.
Link
985. Naturally occurring hepatitis B virus X deletions and insertions among Korean chronic patients.
Lee SA, Mun HS, Kim H, Lee HK, Kim BJ, Hwang ES, Kook YH, Kim BJ.
J Med Virol. 2011 Jan;83(1):65-70.
Link
984. Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections.
Mun HS, Lee SA, Kim H, Hwang ES, Kook YH, Kim BJ.
J Virol. 2011 Jan;85(1):123-32.
Link
983. A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
Kim DW, Lee SH, Lee JS, Lee MA, Kang JH, Kim SY, Shin SW, Kim HK, Heo DS.
Lung Cancer. 2011 Jan;71(1):65-9.
Link
982. Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY.
Br J Cancer. 2009 Jan 27;100(2):298-304. Epub 2009 Jan 6.
Link
981. Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY.
Cancer Sci. 2009 Nov 23. [Epub ahead of print]
Link
980. Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma.
Sim SH, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim TY, Lee JS, Kim YW, Heo DS, Bang YJ.
Lung Cancer. 2009 Aug;65(2):204-7. Epub 2008 Dec 24.
Link
979. The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer.
Sun JM, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Lee JS, Kim YW, Heo DS, Bang YJ.
Lung Cancer. 2009 Aug 10. [Epub ahead of print]
Link
978. The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study.
Yang JJ, Ko KP, Cho LY, Shin A, Gwack J, Chang SH, Shin HR, Yoo KY, Kang D, Park SK.
BMC Cancer. 2009 Jul 17;9:238.
Link